ASAli Akbari Sari

Ali Akbari Sari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali Akbari Sari has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Alireza Olyaeemanesh

    Tehran University of Medical Sciences

    2 shared publications
  • Akbar Fotouhi

    Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Ali Es-Haghi

    Department of Physico Chemistry, Agricultural Research, Education and Extension Organization, Razi Vaccine and Serum Research Institute, Karaj, Iran (the Islamic Republic of)

    1 shared publication
  • Alireza Biglari

    Department of Medical Genetics, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)

    1 shared publication
  • Alireza Nateghian

    Department of Pediatrics, Iran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)

    1 shared publication
  • Amin Adel

    Department of Healthcare Services Management, School of Health Management & Information Sciences, Iran University of Medical Sciences, Tehran, Iran

    1 shared publication

Latest Publications

  • Open Access

    Application of the WHO new vaccine introduction prioritisation and sequencing framework to guide evidence-based vaccine introduction decisions in Iran, 2025–2030

    by Akbar Fotouhi, Sobhan Younesian, Seyede Maryam Mousavi, Seyed Mohsen Zahraei, Sussan Mahmoudi, Farid Fotouhi, Marzieh Nojomi, Maryam Alavi, Omid Zamani, Iraj Sedighi, et al.

    Objectives To document the first application of the WHO New Vaccine Introduction Prioritization and Sequencing Toolkit (NVI-PST) in the WHO Eastern Mediterranean Region and to describe how Iran’s National Immunization Technical Advisory Group (NITAG) adapted and implemented the framework to develop a prioritised roadmap for vaccine introduction during 2025–2030. Design Policy implementation case study applying a structured multicriteria decision analysis-informed prioritisation framework through a three-phase process including framework adaptation, evidence synthesis, ordinal ranking of candidate vaccines, weighted aggregation and development of sequencing scenarios. Setting National immunisation governance process in Iran, coordinated by the Ministry of Health and Medical Education and Iran’s NITAG, with technical support from the WHO Country Office. Participants Core and non-core members of Iran’s NITAG and key immunisation stakeholders involved in the deliberative prioritisation process. Results Human papillomavirus (HPV) vaccine ranked highest in both importance and feasibility, followed by pneumococcal conjugate vaccine (PCV) for high-risk adults and seasonal influenza vaccine for high-risk groups. Two sequencing scenarios were proposed: both placed HPV first, with either PCV or influenza third after the already-approved hexavalent vaccine. Respiratory syncytial virus (RSV) and varicella vaccines were classified as low priority for the 5-year horizon. The toolkit enabled structured multistakeholder deliberation, improved the transparency and reproducibility of prioritisation, and supported systematic integration of epidemiological, economic and programme evidence. The main implementation challenges arose from national evidence constraints, particularly gaps in adult RSV and pneumococcal disease burden, limited locally generated cost-effectiveness analyses and uncertainty in long-term budget impact estimation under macroeconomic instability, rather than from limitations of the toolkit itself. Conclusion The NVI-PST proved feasible under national leadership and generated credible, consensus-based recommendations aligned with Iran’s public health priorities and programme constraints. Minor refinements (streamlined evidence compendium, simpler weighting, stronger secretariat support) would make the toolkit lighter and more sustainable, especially for resource-constrained settings. This Iranian experience provides a replicable model for structured multi-vaccine prioritisation in the Eastern Mediterranean Region and beyond.


  • Open Access

    Comparison of nursing services and consumable costs with tariffs in selected hospitals in 2022

    by Zeinab Fakoorfard, Elham Ehsani-Chimeh, Alireza Olyaeemanesh, Mani Yousefvand, Saeed Manavi, Soheila Damiri, Ebrahim Hassan-Zadeh, Maryam Radinmaneh, Amin Adel, Ali Akbarisari, et al.

    Objective(s): A portion of the financial resources for consumables which are used in inpatient departments in hospitals is entitled nursing services. The tariff of these services currently account for 6%, 4.2%, and 12% of the total income of general, intensive, and burn beds, respectively. This study aimed to compare the costs ...

  • Open Access

    Economic burden of hypertension in Iran: a prevalence-based cost of illness study

    by Rajabali Daroudi, Ali AkbariSari, Mahmoud Zamandi, Zahra Shahali

    Objectives Hypertension is one of the silent diseases and is the major cause of many chronic conditions. The treatment services for hypertension and its cardiovascular complications impose high costs on society and the health system. However, in LMCs, there is not enough evidence-based information about the costs of high blood pressure. This study aims to assess the economic burden of hypertension in Iran in 2020. Design A prevalence-based cost of illness study. Setting Data on hypertension and selected diseases, including their prevalence, incidence, mortality risk and death counts, were sourced from literature reviews, the Global Burden of Disease (GDP) and the Non-Communicable Diseases Research Centre. Cost estimates were derived from health insurance data, surveys, research studies and treatment protocols. Additional data, such as population, employment rates, household activity rates, wage rates and GDP per capita, were obtained from the Statistical Centre of Iran and the World Bank. Participants and methods A prevalence-based cost of illness study was used to estimate the economic burden of hypertension. The focus was on the most significant diseases associated with high blood pressure, including coronary heart disease, ischaemic stroke, haemorrhagic stroke and the direct costs of hypertension. Subsequently, the total number of patients was multiplied by the average cost per patient for each disease. To calculate the average cost, inpatient and outpatient, direct non-medical and indirect costs of diseases were estimated and multiplied by a population-attributed fraction of high blood pressure. Direct costs (hospitalisation and outpatient costs and direct non-medical costs) of hypertension were calculated using the bottom-up approach, and the human capital approach was used to calculate indirect costs. Results According to the results of the study, the total economic burden of hypertension was $ purchasing power parity (PPP) 12 848.22 million, of which the share of direct medical, non-medical and indirect costs of hypertension were $ PPP 7245.13 million (56.4%), $ PPP 1173.42 million (9.1%) and $ PPP 4429.68 million (34.5%), respectively. The total economic burden of high blood pressure was equal to 23% of the total economic burden of four chronic diseases. Conclusion The economic burden of high blood pressure in the country is very high and significant, and it was equivalent to about 1% of the country’s gross domestic product in 2020, which shows the necessity of preventive interventions.


  • Open Access

    Exploring policy processes against microbial threats in Iran: a qualitative policy analysis

    by Azam Raoofi, Amirhossein Takian, Ali Akbari Sari, Masud Yunesian

    Objectives Microbial threats pose a growing concern worldwide. This paper reports the analysis of Iran’s policy process against microbial threats. Design This is a qualitative study. Participants We interviewed 16 purposefully identified key informants selected through snowball sampling. Setting Through the lens of stages heuristic framework, we analysed the interviews by using thematic content analysis. We used MAXQDA V.2020 software for data analysis, identified key themes and subthemes and discussed our findings to validate the results. Results We extracted four main categories in accordance with the stages heuristic domains. Through content analysis of the agenda-setting process, we identified three main themes: magnitude of the problem, actors’ power and priorities. Participants highlighted the significant impact of microbial threats, the influence of powerful stakeholders and the underprioritisation of infectious diseases based on perceived urgency and resources. In the process of policy formulation, we explored three main themes, related to governance, coherence and integration of policies and barriers to effective policy formulation. Governance issues included transparency, engagement with stakeholders, conflict of interest and use of evidence, while coherence and integration of policies focused on insufficient coherence and integration of plans as well as temporary and defensive policymaking. Barriers to effective policy formulation encompassed delay in policymaking, policy gap in response to public needs, weakness in policy feasibility, risk assessment and management. For policy implementation, we extracted governance and coordination, and health system capacity. Effective implementation of policies was hindered by fragmented governance, inadequate communication and accountability and systemic barriers, while health system capacity was limited in terms of infrastructure and human resources. Finally, content analysis of monitoring and evaluation (M&E) resulted in identification of two main themes: discrepancies in M&E and barriers to effective M&E. The discrepancies in M&E varied, with some programmes having regular evaluations and others lacking compliance with international standards. Barriers to effective M&E included inadequate data access, limited information-sharing and inefficiencies in the M&E system. Conclusions Iran needs to prioritise infectious diseases, invest in preventive measures, improve governance and coordination, strengthen health system capacity, enhance M&E and so on, to combat microbial threats effectively. Learning from successful experiences of other countries can help Iran develop more effective strategies to address microbial threats and strengthen global public health in the country.


  • Open Access

    A Scoping Review of Components of Physician-induced Demand for Designing a Conceptual Framework

    by Marita Mohammadshahi, Shahrooz Yazdani, Alireza Olyaeemanesh, Ali Akbari Sari, Mehdi Yaseri, Sara Emamgholipour Sefiddashti

    The current study presents a new conceptual framework for physician-induced demand that comprises several influential components and their interactions. This framework was developed on the basis of the conceptual model proposed by Labelle. To identify the components that influenced induced demand and their interactions, a scoping review was conducted (from January 1980 to January 2017). Additionally, an expert panel was formed to formulate and expand the framework. The developed framework comprises 2 main sets of components. First, the supply side includes 9 components: physicians' incentive for pecuniary profit or meeting their target income, physicians' current income, the physician/population ratio, service price (tariff), payment method, consultation time, type of employment of physicians, observable characteristics of the physician, and type and size of the hospital. Second, the demand side includes 3 components: patients' observable characteristics, patients' non-clinical characteristics, and insurance coverage. A conceptual framework that can clearly describe interactions between the components that influence induced demand is a critical step in providing a scientific basis for understanding physicians' behavior, particularly in the field of health economics.